mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
3e-07 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-07 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-07 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
6e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |